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Riding in silence: a little snowboarding, a lot of
small RNAs
Stefan L Ameres*, Ryuya Fukunaga*
Abstract
The recent symposium, RNA silencing: Mechanism, Biology and Applications, organized by Phillip D. Zamore
(University of Massachusetts Medical School) and Beverly Davidson (University of Iowa), and held in Keystone,
Colorado, brought together scientists working on diverse aspects of RNA silencing, a field that comprises a
multitude of gene regulatory pathways guided by microRNAs, small interfering RNAs and PIWI-interacting RNAs.
Review
From 14 to 19 January 2010, small RNAs once again
attracted the attention of more than 500 attendees to
symposium on RNA silencing: Mechanism, Biology and
Applications, held in Keystone, Colorado. In the midst
of the breathtaking panorama of the Rocky Mountain
summits, exciting and rapidly evolving science mixed
with superb riding and skiing created a stimulating
atmosphere for discussions on the mechanisms, biology
and applications of RNA silencing.
Biogenesis of small RNAs
A much-discussed topic at the meeting was the mechan-
isms and regulation of micro (mi)RNA biogenesis. In
her keynote address, Narry Kim (Seoul National Univer-
sity) elaborated on the effect of pre-miRNA uridylation.
She reported that the terminal uridylyl transferase,
TUT4, acts on the 3’ termini of pre-miRNAs to suppress
pre-miRNA processing [1,2]. Although this process
requires the scaffold protein Lin-28 to recruit the
TUTase to specific pre-miRNAs, uridylation is not lim-
ited to these pre-miRNAs. Whereas oligo-uridylylation
inhibits pre-miRNA dicing, mono-uridylylation can
enhance pre-miRNA processing by human and fly Dicer
proteins in vitro, suggesting that post-transcriptional
pre-miRNA modification can have a versatile effect on
processing. Surprisingly, the addition of one or a few
additional nucleotides to the 3’ end of a pre-miRNA did
not alter the 3’ end of the miRNA excised from the 5’
side of the stem. To explain these data, Kim proposed
an alternative model to the PAZ-anchored molecular
ruler model that emerged from the structure of Giardia
Dicer [3]. She suggested that Dicer proteins in higher
eukaryotes measure mainly from the 5’ end of a pre-
miRNA, rather than from its 3’ end.
Jennifer Doudna (University of California, Berkeley)
described the first structural insights into human pre-
miRNA processing and loading by electron microscopy
[4]. She presented biochemical cross-linking studies
employing a recombinant human Dicer-TRBP (trans acti-
vation response RNA binding protein) complex. These
data suggest that the human proteins, ‘sense’ the thermo-
dynamic asymmetry of the ends of a small RNA duplex, as
was originally proposed for their fly counterparts, Droso-
phila Dicer-2 and R2D2 [5]. For both the human and fly
proteins, the double-stranded (ds)RNA binding partner of
Dicer binds to the more stable end of a small interfering
(si)RNA duplex, directing the preferential loading into
Argonaute of the siRNA strand, whose 5’ end is less stably
paired. PACT (protein activator), the other dsRNA-bind-
ing partner of human Dicer, showed similar behavior in
these studies. Despite this similarity, the two dsRNA-bind-
ing partners of Dicer had opposite effects on pre-miRNA
processing: TRBP activated dicing thus increasing turn-
over, whereas PACT inhibited dicing. Thus dsRNA-bind-
ing dicer partner proteins may tune Dicer activity.
Dinshaw Patel (Memorial Sloan-Kettering Cancer Cen-
ter) presented the structure of a budding yeast Dicer pro-
tein from Saccharomyces castellii. This ‘Dicer’ lacks a
PAZ domain, which normally allows Dicer to recognize
the two-nucleotide 3’ overhang of small RNA precursors,
and contains only a single RNase III domain. The
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structure revealed that the protein dimerizes to generate
two catalytically active centers, with each having the
potential to cleave one strand of the dsRNA, leaving
duplex ends with overhangs two nucleotides in length.
The uniform product length (23 nucleotides) observed in
vitro, may reflect dimer-dimer interactions on duplex
RNA, a novel strategy to assure a uniform length of Dicer
products in a small RNA pathway.
A hitherto underappreciated feature of Dicer proteins
in higher eukaryotes is the helicase domain, the function
of which is not understood. Brenda Bass (University of
Utah) showed that in Caenorhabditis elegans the helicase
domain is dispensable for pre-miRNA processing; expres-
sion of a helicase mutant Dicer in Dicer null mutant ani-
mals rescued the phenotype caused by loss of miRNAs.
However, deep sequencing revealed that Dicer helicase
mutants lose primary endo-siRNAs. In vitro processing
experiments suggest that the structure of endo-siRNA
precursor dsRNAs versus the structure of pre-miRNAs
might be the discriminating factor, because dsRNA bear-
ing a blunt end or a 5’ overhang could not be processed
by a Dicer lacking a functional helicase domain.
The initial step in miRNA biogenesis, primary (pri)-
miRNA processing, can be modulated by accessory pro-
teins such as SMAD proteins, as reported by Brandi
Davis (Tufts University) [6]. Davis described experi-
ments that suggest that SMAD proteins associate with
p68, Drosha and DGCR8 on the pri-miRNA to promote
conversion of the pri-miRNA into a pre-miRNA. The
recognition step might rely on a conserved sequence in
the center of the designated mature miRNA.
In the second keynote address, James Carrington
(Oregon State University) talked about the mechanisms
that produce trans-acting siRNA (tasi-RNA) in plants
[7-9]. The association of miR-173 with Ago1 and miR-
390 with Ago7 is required to generate precise ends on
TAS1 or TAS3 loci transcripts, respectively, and are
required for the recruitment of an RNA-dependent
RNA polymerase to generate dsRNA that is then further
processed into tasi-RNAs. Besides the importance of the
5’ nucleotide of a miRNA in determining its association
with particular Argonaute proteins, the length of miR-
NAs also seems to be important for tasi-RNA formation:
miRNAs involved in generation of tasi-RNAs are predo-
minantly 22 nucleotides long, whereas plant miRNAs in
general are mostly 21 nucleotides long. Interestingly,
shortening miR-173 from 22 to 21 nucleotides interfered
with the generation of tasi-RNAs from the TAS1 locus,
although neither its loading into Ago1 nor its ability to
cleave the TAS1 transcript was altered.
miRNA function
A series of talks described new insights into the
mechanism of small RNA function in various organisms.
David Bartel (Massachusetts Institute of Technology)
presented compelling genome-wide support for the
recent idea that much of the repression mediated by
miRNAs reflects mRNA destabilization rather than
translational repression [10,11]. He described ribosome-
profiling experiments [12] in the presence or absence of
specific miRNAs. Changes in ribosome-protected frag-
ments mostly reflected changes in mRNA levels,
whereas there was only a small, although detectable,
change in ribosome density on miRNA-regulated tran-
scripts. This was much of a surprise to most in the
audience, because translational repression has long been
considered to be the major mechanism of miRNA func-
tion. A lively and extended question and answer session
followed the talk!
Phillip Zamore (University of Massachusetts Medical
School) speculated on the puzzling discrepancy between
the nature of miRNA targets in plants and animals. In
plants, miRNAs usually pair with high or perfect com-
plementarity to their targets, whereas in animals pairing
is usually limited and is often restricted to only the
‘seed region’ (nucleotides 2 to 8) of the miRNA guide.
He showed that in Drosophila, extensive complementar-
ity between miRNAs and their target RNAs leads to tail-
ing and degradation of miRNAs. Interestingly, flies have
a small RNA protection system that is based on the
methyltransferase Hen1, and methylates small RNAs
associated with Ago2, the effector protein in the RNAi
pathway. The methylation of small RNAs at their 3’
terminal ribose counteracts tailing and degradation, and
is required to ensure the integrity and abundance of
endogenous small RNAs in Drosophila. In plants, all
miRNAs are methylated, which might have allowed
high-complementarity targets to evolve. Interestingly,
the target-dependent small RNA tailing and degradation
machinery seems to be conserved in humans.
Tudor Fulga (Harvard Medical School) introduced a
powerful tool to study miRNA function in flies [13].
The expression of miRNA sponges (originally estab-
lished by Phil Sharp’s group in mammalian cell lines
[14]) allows uncovering of miRNA null mutant pheno-
types with spatiotemporal resolution in transgenic flies
employing the Gal4-UAS system. Although it is still
unclear if miRNA sponges work via competition or
miRNA degradation, this system will be a valuable tool
to understand miRNA function in model organisms
such as Drosophila melanogaster.
Victor Ambros (University of Massachusetts Medical
School) gave an update on how the tripartite motif
(TRIM)-NHL protein, NHL-2, functions as a cofactor
for miRNA-induced silencing by enhancing post-tran-
scriptional repression of target mRNAs [15]. NHL-2
associates with CGH-1 (a P-body component) and the
Argonaute proteins, ALG-1 and ALG-2, and these
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interactions are ATP-dependent. Dr Ambros also
reported novel alg-1 mutants identified in a screen for
genetic suppressors of lin-28. These alg-1 mutations
affect amino acids in or surrounding the PIWI domain
and act as antimorphic mutations because they have a
more detrimental effect on the organism than does a
null mutant. Such an effect might be explained by a
possible competition of mutant Alg-1 with Alg-2, which
in an alg-1 null mutant can take over miRNA
regulation.
Martijn Kedde (Netherlands Cancer Institute)
described a switch in RNA structure in the 3’ untrans-
lated region (UTR) of p27 that regulates miRNA access
to its binding site. He suggested that the RNA-binding
protein, Pumilio, binds to the p27 3’ UTR in cycling
cells, opening a hairpin structure and thereby increasing
the accessibility of miRNA binding sites to miR-221 and
miR-222. Growth factor stimulation changes the phos-
phorylation status of Pumilio, which modifies its affinity
for the p27 3’ UTR binding sites. This might contribute
to the upregulation of p27 in quiescent cells, providing
the basis for a novel RNA-binding protein-induced
switch that modulates miRNA-mediated gene regulation.
In the first part of his talk, Dinshaw Patel presented
structural insights into the ternary interaction and struc-
tural rearrangements associated with the Thermus ther-
mophilus Argonaute protein, its associated guide DNA,
and a target RNA [16]. He also gave an outlook on a
novel structure of the bacterial Argonaute protein
bound to an uncleaved DNA target, which allowed
investigation of rearrangements at the catalytic center of
the wild-type protein. He found that upon formation of
15 perfect base pairs between the DNA guide and its
target, Argonaute undergoes conformational transitions
that lock it into a catalytically competent state, position-
ing a divalent cation near the scissile phosphate.
Eliza Izaurralde (Max Planck Institute for Develop-
mental Biology) reported that the interaction between
PABC1 and the silencing domain of GW182 results in
competition for eIF4G binding to the 5’ cap, ultimately
interfering with mRNA circularization [17]. This
increases the accessibility of the mRNA 3’ end to deade-
nylating enzymes, contributing to miRNA-mediated
destabilization of mRNAs.
Gene Yeo (University of California, San Diego) dis-
cussed the recent identification of endogenous Argo-
naute binding sites in C. elegans using cross linking,
ALG1 immunoprecipitation, and high-throughput
sequencing (HITS) (with crosslinking immunoprecipita-
tion (HITS-CLIP or CLIP-Seq)) [18]. Yeo and his colla-
borators are currently trying to identify Argonaute
binding sites in human stem cells, which exhibit miRNA
expression profiles distinct from common human cell
lines.
Biology of small RNAs
Several talks at the meeting reiterated the multifarious
character of miRNAs, being involved in the regulation
of a plethora of biological processes. In the second part
of her keynote lecture, Narry Kim reported that miR-8/
miR-200 regulate body weight homeostasis in flies and
mice [19]. miR-8 in flies and miR-200 in humans target
USH (Usher syndrome)/FOG2 (friend of Gata 2), which
in turn inhibits phosphoinositide 3-kinase (PI3K). Loss
of those miRNAs therefore activates fat cell growth
through increased PI3K activity. Their study identified
two novel regulators of insulin signaling, USH/FOG2
and miR-8/miR-200.
Craig Mello (University of Massachusetts Medical
School) presented an historic overview of small RNA
pathways in C. elegans, emphasizing a class of endo-siR-
NAs called 22G-RNAs. Several distinct 22G-RNA sys-
tems act in worms. In the germline, one system requires
worm-specific AGOs, including WAGO-1, an Argonaute
that localizes to germ line nuage structures and silences
certain genes, transposons, pseudogenes and cryptic loci
[20]. In association with the Argonaute CSR-1, 22G-
RNAs localize to chromosomes and are required for
proper chromosome segregation [21].
Phil Sharp (Massachusetts Institute of Technology)
talked about the role of miRNAs in mammalian cell
robustness. He showed that although misexpression of
miRNAs was repeatedly found to be associated with cer-
tain types of cancer, miRNA regulation is not essential
for cancer. A tumor cell line that is defective for
miRNA synthesis can still form tumors. In a reporter
cell line, Dr Sharp tested the threshold for miRNA-
mediated repression under increased transcription rates
and found that at low levels of reporter expression,
miRNA-mediated repression is strongest, and that high
expression almost completely relieves this type of regu-
lation. Finally, he showed that during stress, the cyto-
plasmic subcellular localization of mRNAs and miRNAs
is dependent upon formation of poly(ADP-ribose) and
that miRNA repression is reduced under these
conditions.
Deepak Srivastava (Gladstone Institute of Cardiovascu-
lar Disease) talked about miRNA regulation of cardio-
vascular cell fate. He elaborated on individual miRNAs
that govern differentiation and development of embryonic
stem cell-derived and induced pluripotent stem cell-
derived multipotent cardiac progenitors into cardiomyo-
cytes, endothelial and smooth muscle cells, thereby
emphasizing the potential of miRNA manipulation in
influencing the outcome of cell fates and of cellular
homeostasis.
Mark Boldin (Regulus Therapeutics) showed that miR-
146a is an endotoxin-responsive miRNA, and miR-146
knockout mice are hypersensitive to bacterial challenge
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and develop a spontaneous autoimmune-like disorder.
He suggested that miR-146a serves as a molecular brake
for both the inflammatory response and oncogenic
transformation of immune cells.
Dasaradhi Palakodeti (University of Connecticut
Health Center) discussed the involvement of small
RNAs in the regenerative capabilities of the planarian
Schmittea mediterrenea. The regeneration of lost tissues
and organs from neoblasts (the equivalents of stem cells
in higher organisms) is sensitive to irradiation, which
depletes the animals of neoblasts. Knockdown of Smed-
Ago1 by RNA interference (RNAi) leads to drastic
regeneration defects and a decrease in the neoblast
population, implicating the miRNA pathway in regen-
eration and neoblast function in planaria.
Small RNAs in chromatin formation
Sarah Elgin (Washington University) discussed the
diminutive Drosophila melanogaster ’dot’ chromosome,
which is mainly occupied by heterochromatin bearing
HP1 and H3K9 dimethylation, causing variegated
expression of transgenes inserted into diverse regions of
the fourth chromosome. Silencing of reporters inserted
into the 4th chromosome can be suppressed by muta-
tions in aubergine and piwi. HP1 binds to PIWI in vitro,
and in the germline, PIWI is needed for HP1 localiza-
tion at the promoter region of HeT-A transposons.
Shiv Grewal (National Institutes of Health) showed
that in Schizosaccharomyces pombe, the histone methyl-
transferase Clr4 is required for generation of centro-
meric siRNAs, partly independent of its role in
methylation of histone H3 lysine 9. He presented evi-
dence suggesting that the Clr4 complex and the RNAi
effector complex, RNA-induced transcriptional silencing
(RITS), might be recruited to chromatin in a cooperative
manner. He also showed that loss of either Clr4 or Ago1
in the absence of functional H2A.Z increases the levels
of antisense transcripts, which are usually suppressed
with assistance of Dicer and the exosome. He proposed
a model in which heterochromatin and RNAi compo-
nents cooperate with a variant histone H2A.Z to sup-
press non-coding and antisense transcripts.
Danesh Moazed (Harvard Medical School) described
Dicer-independent ‘primal small RNAs’ (priRNAs) in S.
pombe [22]. These 22-23-nucleotide RNAs posses a 5’ ura-
cil bias and specifically associate with Argonaute1. priR-
NAs map to the 3’ UTR of mRNAs and to non-coding
RNAs in centromeric repeat regions, where they mediate
low levels of H3K9 methylation. Convergent transcripts
from centromeric repeats might give rise to antisense
priRNAs, which cause siRNA amplification through the
RNA-dependent RNA polymerase complex and Dicer-1.
Stephan Emmerth (Friedrich Miescher Institute)
showed that Dicer-1 in the fission yeast S. pombe is
localized to the nucleus and is enriched in the nuclear
periphery [23]. Localization requires a short motif,
which constrains nuclear export promoted by the
dsRNA binding domain of Dicer-1. Deletion of this
motif results in localization of Dcr1 to the cytoplasm
and causes marked changes in gene expression and fail-
ure to assemble heterochromatin.
RNAi and therapeutics
Beverly Davidson (University of Iowa) talked about ther-
apeutic strategies to target Huntington’s disease (HD).
Preliminary in vivo experiments in established mouse
models of this fatal neurodegenerative disorder indicated
disease improvement after silencing both mutant and
wild-type huntingtin alleles via RNAi. This could pro-
vide an important alternative approach to the as yet
untested single nucleotide polymorphism-based therapy,
which may be useful in ~75% of patients with HD. In
additional work, she showed that dysregulation of miR-
NAs in brains from patients with HD might contribute
to its varying clinical presentations and disease course.
Priti Kumar (Yale School of Medicine) presented pro-
gress in strategies for delivering siRNAs into T cells for
antiviral therapy. She described a CD7-specific single-
chain antibody conjugated to oligo-9-arginine peptide
[24] or lymphocyte function-associated antigen (LFA)-1
integrin antibody conjugated to stabilized nanoparticles
[25].
Daniel G. Anderson (Massachusetts Institute of Tech-
nology) elaborated on the combinatorial development of
nucleic acid delivery agents using a high throughput
approach to develop biomaterials. He provided updates
on the second generation of siRNA delivery formula-
tions, which allow efficient knockdown in vivo by doses
as low as 0.03 mg/kg in non-human primates [26]. He
also showed preliminary performance tests for simulta-
neous knockdowns of up to 10 genes.
Sakari Kauppinen (Santaris Pharma) described tiny
locked nucleic acid (LNA) antisense oligonucleotides
targeting the seed of miRNAs to repress their function.
An LNA-anti-miR (SPC3649) targeting miR-122 in the
liver has previously been used in mice and non-human
primate studies to induce a long-lasting decrease in
serum cholesterol, and the success story of this LNA
compound continues, because the same strategy has
been introduced as a new anti-hepatitis C virus therapy
in chronically infected chimpanzees [27]. Clinical trials
for SPC3649 are ongoing, and Kauppinen reported that
the molecule seems to be well tolerated and shows effi-
cacy in healthy human volunteers.
PIWI-interacting (pi)RNAs
Mikiko Siomi (Keio University School of Medicine)
described the specific association of a Tudor domain-
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containing protein, Tudor, with Aubergine and Ago3
through symmetric dimethyl-arginine (sDMA) modifica-
tions in the PIWI proteins introduced by dPRMT5/Cap-
suleen/DART5. She suggested that this might be
involved in the loading of primary PIWI-interacting (pi)
RNAs into the effector PIWI proteins [28]. Studies in a
fly ovarian somatic cell line expressing PIWI but not
Aubergine or Ago3, indicate that PIWI and the RNA
helicase Armitage (Armi) but not Maelstrom (Mael) or
Spindle-E (Spn-E) (both factors implicated in the piRNA
pathway in flies) are required for piRNA accumulation.
Armi co-localizes with the helicase and Tudor domain-
containing protein, Yb, to distinct foci in the cytoplasm
called Yb bodies. Similar colocalization can be observed
in fly ovaries and testes. In a model, PIWI and Armi
were proposed to be involved in primary piRNA accu-
mulation in Yb bodies, whereas Mael and Spn-E might
participate in the ‘ping-pong’ amplification loop.
René Ketting (Royal Netherlands Academy of Arts and
Sciences) presented novel insights into the zebrafish
piRNA pathway. Ziwi and Zili, the two zebrafish PIWI
proteins, localize to nuage, a germline-specific perinuc-
lear structure, and associate with antisense and sense
piRNAs, respectively, exhibiting the characteristic ping-
pong signature. As in other animals, zebrafish piRNAs
bear a 2’-O-methyl group on their 3’ terminal nucleo-
tide, which protects them from uridylation and destabili-
zation. Interestingly, mutants in the methyltransferase,
Hen1, only develop into males, which are fertile. This is
in contrast to Piwi mutant males, which are sterile, sug-
gesting that in hen1 mutants the piRNA pathway is dis-
turbed rather than disrupted. Again as in flies, the two
zebrafish Piwi proteins bear sDMA modifications
required for binding to Tdrd1. Tdrd1 associates with
piRNA precursor transcripts and thus may function in
substrate selection. Furthermore, PIWI proteins are
required for meiosis and cell differentiation in a manner
that is not related to transposon silencing.
Alex Bortvin (Carnegie Institution of Washington)
suggested that an evolutionarily conserved gene, mael-
strom, is needed for transposon silencing in the male
mouse germline, and for proper chromosome synapsis
and crossing over in both male and female meiosis [29].
Conclusions
The conference highlighted the expanding roles of
small-silencing RNAs in various biological systems, their
finely tuned biogenesis, regulatory mechanisms and
potential as therapeutics. It is exciting to see that after a
decade of intensive study, the field is not running out of
surprises. In fact, many of the presentations raised capti-
vating questions that left the attendees of the meeting
yearning for next year’s conference.
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